Trade Summary

3 days ago, Gilson Michelle, serving as CFO at Arcellx, Inc. (ACLX), sold 8,384 shares at $68.29 per share, for a total transaction value of $572,568.00. Following this transaction, Gilson Michelle now holds 45,157 shares of ACLX.

This sale represents a 16.00% decrease in Gilson Michelle's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, February 19, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, meaning the disclosure happened on the same day as the trade.

Arcellx, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.